- Home
- MYGN vs VECO Comparison
MYGN vs VECO Comparison
Compare MYGN & VECO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MYGN
- VECO
- Stock Information
- Founded
- MYGN 1991
- VECO 1945
- Country
- MYGN United States
- VECO United States
- Employees
- MYGN N/A
- VECO N/A
- Industry
- MYGN Biotechnology: In Vitro & In Vivo Diagnostic Substances
- VECO Industrial Machinery/Components
- Sector
- MYGN Health Care
- VECO Technology
- Exchange
- MYGN Nasdaq
- VECO Nasdaq
- Market Cap
- MYGN 744.7M
- VECO 1.2B
- IPO Year
- MYGN 1995
- VECO 1994
- Fundamental
- Price
- MYGN $5.34
- VECO $21.14
- Analyst Decision
- MYGN Hold
- VECO Buy
- Analyst Count
- MYGN 15
- VECO 7
- Target Price
- MYGN $15.14
- VECO $30.43
- AVG Volume (30 Days)
- MYGN 1.3M
- VECO 628.4K
- Earning Date
- MYGN 08-05-2025
- VECO 08-05-2025
- Dividend Yield
- MYGN N/A
- VECO N/A
- EPS Growth
- MYGN N/A
- VECO N/A
- EPS
- MYGN N/A
- VECO 1.07
- Revenue
- MYGN $831,300,000.00
- VECO $710,109,000.00
- Revenue This Year
- MYGN N/A
- VECO N/A
- Revenue Next Year
- MYGN $6.68
- VECO $10.08
- P/E Ratio
- MYGN N/A
- VECO $19.85
- Revenue Growth
- MYGN 7.38
- VECO 3.30
- 52 Week Low
- MYGN $3.81
- VECO $16.92
- 52 Week High
- MYGN $29.30
- VECO $49.25
- Technical
- Relative Strength Index (RSI)
- MYGN 50.85
- VECO 53.78
- Support Level
- MYGN $4.90
- VECO $20.84
- Resistance Level
- MYGN $5.83
- VECO $21.62
- Average True Range (ATR)
- MYGN 0.28
- VECO 0.68
- MACD
- MYGN 0.04
- VECO 0.03
- Stochastic Oscillator
- MYGN 54.21
- VECO 71.78
About MYGN Myriad Genetics Inc.
Myriad Genetics Inc is a molecular diagnostics company that provides testing services designed to assess an individual's risk of developing a disease. The firm produces MyRisk, a 48-gene panel capable of identifying the elevated risk of developing 11 types of cancer. Other diagnostic products include BRACAnalysis CDx, the FDA-approved companion diagnostic for PARP inhibitors; GeneSight, which helps improve responses to psychotropic drugs for patients suffering from depression; and Prequel, a noninvasive prenatal test. Precise Oncology Solutions, launched in 2022, combines Precise Tumor with companion diagnostic and prognostic tests such as MyChoice CDx, Prolaris, and EndoPredict. The firm also offers pharma and biotech companies biomarker discovery and companion diagnostic services.
About VECO Veeco Instruments Inc.
Veeco Instruments Inc is a United States-based company engaged in designing, developing, and manufacturing thin-film process equipment, mainly used for producing electronic devices. The company focuses on semiconductor process equipment that addresses a range of challenging materials engineering problems for our customers. Its products include Laser Processing Systems, Lithography Systems, Ion Beam Systems, SiC CVD Systems, MOCVD Systems, Wet Processing Systems, MBE Technologies, Atomic Layer Deposition Systems, Physical Vapor Deposition Systems, Dicing and Lapping Systems, as well as Gas & Vapor Delivery Systems. The majority of the company's revenue is generated from sales to the Semiconductor Industry and within China.